Dapagliflozin Tetraacetate, Dapagliflozin intermedju
| Isem Kimiku | Dapagliflozin Tetraacetate;Dapagliflozin intermedju |
| Sinonimi | (2R,3R,5R,6R)-6-(Acetoxymethyl)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate; [(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-il]methyl acetate |
| Numru CAS | 461432-25-7 |
| Formula Molekulari | C₂₉H₃₃ClO₁₀ |
| Dehra | Solidu abjad għal Off-White |
| Punt tat-tidwib | 180.7±30.5 °C |
| Piż Molekulari | 577.019 |
| Ħażna | Atmosfera inerta |
| Kategorija | Standards;Impuritajiet/Metaboliti tad-Droga Farmaċewtiċi/API; |
| Applikazzjonijiet | Dapagliflozin Tetraacetate huwa derivat ta' Dapagliflozin [D226255], inibitur ta' sodium-glucose transporter 2. |
| Referenzi | Kasichayanula, S. et al.: Diabetes, Obesity and Metabolism 13, 47 (2011);Bernhardson, D. et al.: Org.Proc.Riż.Dev., 18, 57 (2014); |
Isem tal-Prodott:Dapagliflozin Tetraacetate, Dapagliflozin intermedju, CAS NO: 461432-25-7
Sinonimi:
Dapagliflozin Tetraacetate, Dapagliflozin intermedju;
(2R,3R,5R,6R)-6-(Acetoxymethyl)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate;
[(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate;
(1s)-1,5-anhydro-1-c-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-d-glucitoltetraacetate;
Aċidu aċetiku (2R,3R,4R,5S,6S)-3,4,5 - triacetoxy-6-[4-chloro -3-(4-ethoxy-benzyl) -phenyl]-tetrahydro-pyran-2-ylmethyl ester
(1S)-2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
Dapagliflozin-A3
(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate
Anhui Cheer-Our Medical technology Co., Ltd ġiet stabbilita fl-2015. Wara kontinwazzjoni 'l quddiem, il-kumpanija żviluppat f'intrapriża farmaċewtika ta' teknoloġija għolja li tintegra r-riċerka tad-droga kimika u bijoloġika, intermedji farmaċewtiċi, APIs, preparazzjonijiet u bejgħ ta 'prodotti.Permezz tar-riċerka u l-iżvilupp u l-innovazzjoni fil-qasam tal-mediċina u s-saħħa bħal mediċini lesti, APIs u intermedji, il-kumpanija taderixxi mal-prinċipju tal-klijent l-ewwel, servizz onest, kwalità l-ewwel, benefiċċju reċiproku", permezz ta 'ttestjar perfett, ta' kwalità għolja servizz, jipprovdi sintesi tad-dwana, manifattura ta 'kuntratt u servizzi ta' pproċessar.
1. Kwalunkwe inkjesta jew messaġġ se tingħata tweġiba fi żmien 12-il siegħa.
2. Manifattur professjonali.Merħba żur il-websajt tagħna.
3. API, Intermedju huma disponibbli, nistgħu noffru Custom Synthesis, u reġistrazzjoni wkoll.
4. Twassil veloċi.
5. Servizzi ta 'wara l-bejgħ
